Ardelyx, Inc. (ARDX) Stock Forecast

NASDAQ: ARDXAnalyst ratings, price target and estimates.

ARDX analyst forecast

as of October 18, 2026
Analyst consensus
Strong buy
4.91 / 5 from 11 analysts
Price target
$12.90
average of analyst targets
Upside to target
+317.5%
from the latest close
Next earnings
October 29, 2026
EPS estimate $-0.03
52-week range
$3.09 – $7.99

ARDX analyst ratings

11 analysts
Strong buy
1091%
Buy
19%
Hold
00%
Sell
00%
Strong sell
00%

Number of analysts at each rating.

ARDX price target

Price $3.09Target $12.90
52-week low $3.0952-week high $7.99

The average of analyst 12-month price targets compared with the latest close and the 52-week range.

ARDX earnings per share estimates

Ardelyx, Inc. EPS estimates
PeriodAverageLowHighYear agoGrowthAnalysts
Current quarter (Sep '26)−$0.02−$0.06$0.02$0.000.0%8
Current fiscal year (2026)−$0.19−$0.26−$0.10−$0.26+27.6%8
Next fiscal year (2027)$0.29$0.03$0.63−$0.19+254.3%8

Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.

ARDX revenue estimates

Ardelyx, Inc. revenue estimates
PeriodAverageLowHighGrowthAnalysts
Current quarter (Sep '26)$129.0M$119.6M$134.5M+17.0%11
Current fiscal year (2026)$488.7M$475.2M$503.0M+20.0%11
Next fiscal year (2027)$624.1M$563.1M$743.5M+27.7%11

ARDX EPS: reported and forecast

Reported EPSEstimate (average; low–high)

Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.

ARDX revenue: reported and forecast

Reported revenueEstimate (average; low–high)

ARDX EPS estimate revisions

Ardelyx, Inc. EPS estimate revisions
Period90 days ago60 days ago30 days ago7 days agoNowChange (90 d)Revisions (30 d)
Current quarter (Sep '26)$0.04$0.04−$0.02−$0.01−$0.02−136.3%0 up · 1 down
Current fiscal year (2026)−$0.05−$0.07−$0.20−$0.19−$0.19+293.9%0 up · 2 down
Next fiscal year (2027)$0.52$0.49$0.25$0.30$0.29−43.6%0 up · 1 down

How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.

ARDX earnings surprises

Reported EPSEstimate

Reported EPS vs the consensus estimate for the last 12 quarters; ARDX beat in 8 of 12.

What analysts expect from ARDX

11 analysts cover Ardelyx; their consensus rating is strong buy (4.91 on a 1–5 scale, where 5 is a strong buy). The average price target is $12.90, 317.5% above the latest close of $3.09. Analysts expect earnings of −$0.19 per share for 2026, +27.6% from a year earlier. For 2027 the average estimate is $0.29 per share on revenue of $624.1 million. Ardelyx beat the EPS estimate in 8 of the last 12 quarters.

Related: ARDX income statement, ARDX key metrics, ARDX chart. See the ARDX stock overview for the latest quote and news.

ARDX forecast FAQ

What is Ardelyx's price target?

The average analyst price target for Ardelyx is $12.90, 317.5% above the latest close of $3.09.

Is Ardelyx a buy, hold or sell?

Of 11 analysts covering Ardelyx, 10 rate it a strong buy, 1 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.

What is Ardelyx's EPS forecast?

Analysts forecast −$0.19 per share for 2026 (range −$0.26 to −$0.10); for 2027 the estimate is $0.29.

What is Ardelyx's revenue forecast?

The average revenue estimate for 2026 is $488.7 million, growth of 20.0%; for 2027 it is $624.1 million.

When does Ardelyx report earnings?

Ardelyx is expected to report results for the quarter ending September 30, 2026 on October 29, 2026 after the market closes; the EPS estimate is $-0.03.

Does Ardelyx usually beat earnings estimates?

Ardelyx reported EPS at or above the analyst estimate in 8 of the last 12 quarters.

Biotechnology: forecast